Dicerna Pharmaceuticals, Inc. DRNA today announced the appointment of
John "Jack" Green as interim chief financial officer (CFO), effective
January 1, 2016. He replaces James Dentzer, whose departure is also
announced today.
Mr. Green is a Certified Public Accountant with over 30 years of
financial management experience, including more than 20 years within the
biotechnology industry. Concurrently to serving as part-time, interim
CFO at Dicerna, Mr. Green will continue in a part-time capacity as CFO
of Verastem, Inc. (VSTM). Previously, he served for more than 15 years
as CFO of GTC Biotherapeutics (formerly Genzyme Transgenics), a publicly
traded biotech company spun out of Genzyme as a
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in